https://www.selleckchem.com/pr....oducts/bupivacaine.h
To establish age-adjusted reference values for prostate-specific antigen in an ethnically diverse population. Between 2009 and 2017, data were collected from all men aged 40-79years, who had a prostate-specific antigen test in the northern region of New Zealand, where the prostate-specific antigen testing service is provided by a single community laboratory and using the same assay analyzer. Men known to have prostate cancer, who developed prostate cancer during the study period, who were treated with finasteride, or who had prostat